Oncolytics Biotech’s Financials Show Asset Decline
PremiumCompany AnnouncementsOncolytics Biotech’s Financials Show Asset Decline
2M ago
Oncolytics Biotech Advances Cancer Trials with Solid Funding
Premium
Company Announcements
Oncolytics Biotech Advances Cancer Trials with Solid Funding
2M ago
Oncolytics reports Q2 EPS (10c), consensus (7c)
Premium
The Fly
Oncolytics reports Q2 EPS (10c), consensus (7c)
2M ago
Oncolytics Biotech CEO Takes Medical Leave
PremiumCompany AnnouncementsOncolytics Biotech CEO Takes Medical Leave
3M ago
Oncolytics CEO Matt Coffey, PhD to take a medical leave of absence
Premium
The Fly
Oncolytics CEO Matt Coffey, PhD to take a medical leave of absence
3M ago
Oncolytics Biotech Advances Pancreatic Cancer Study
Premium
Company Announcements
Oncolytics Biotech Advances Pancreatic Cancer Study
3M ago
Oncolytics Biotech Joins Forces to Battle Pancreatic Cancer
PremiumCompany AnnouncementsOncolytics Biotech Joins Forces to Battle Pancreatic Cancer
4M ago
Oncolytics Biotech Joins GCAR for Cancer Trial
Premium
Company Announcements
Oncolytics Biotech Joins GCAR for Cancer Trial
4M ago
Oncolytics announces preliminary collaboration with GCAR
Premium
The Fly
Oncolytics announces preliminary collaboration with GCAR
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100